QS Investors’s Regenxbio RGNX Stock Holding History

QS Investors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$319K	Hold	8,200	–	–	﹤0.01%	924
2021 Q1	$280K	Sell	8,200 -120	-1%	-$5.12K	﹤0.01%	1009
2020 Q4	$377K	Hold	8,320	–	–	﹤0.01%	909
2020 Q3	$229K	Sell	8,320 -32,000	-79%	-$1.04M	﹤0.01%	1027
2020 Q2	$1.49M	Hold	40,320	–	–	0.02%	601
2020 Q1	$1.31M	Hold	40,320	–	–	0.02%	580
2019 Q4	$1.57M	Sell	40,320 -625	-2%	-$24.7K	0.02%	660
2019 Q3	$1.46M	Hold	40,945	–	–	0.02%	664
2019 Q2	$2.1M	Sell	40,945 -1,000	-2%	-$49.9K	0.02%	571
2019 Q1	$2.4M	Hold	41,945	–	–	0.03%	527
2018 Q4	$1.76M	Hold	41,945	–	–	0.02%	597
2018 Q3	$3.17M	Buy	+41,945	New	+$3.02M	0.03%	451

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QS Investors's RGNX Position: Q2 2021 in Review

QS Investors held its Regenxbio (RGNX) position steady in Q2 2021 at 8,200 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

QS Investors first reported a position in RGNX in Q3 2018 and has held it in 12 quarters since. The position peaked at $3.17M in Q3 2018. 172 funds tracked by Wall St. Rank hold RGNX as of Q2 2021.

QS Investors held 8,200 shares of Regenxbio worth $319K as of Q2 2021.
QS Investors left its Regenxbio share count unchanged in Q2 2021.
Regenxbio made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #924 holding.
QS Investors first reported a position in Regenxbio in Q3 2018 and has held it in 12 quarters since.
QS Investors's Regenxbio position peaked at $3.17M in Q3 2018.
172 funds tracked by Wall St. Rank held Regenxbio as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.